Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Lee

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2018
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic RatioWai-Tong Ng, Stewart Y Tung, Victor Lee, et al.
The American Journal of Surgical Pathology|March 2, 2026
Does This Imaging Make Me Look NFATC2? The Value of Radiologic-pathologic Correlation in NFATC2-rearranged Sarcomas of BoneMichael E Kallen, Raul Perret, Gregory W Charville, et al.
Cancers|September 10, 2021
External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal CarcinomaPui-Lam Yip, Shing-Fung Lee, Cheuk-Wai Horace Choi, et al.
Targeted Oncology|January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in ChinaHai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
The Lancet. Oncology|June 21, 2013
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trialYi-Long Wu, Jin Soo Lee, Sumitra Thongprasert, et al.
Science Translational Medicine|April 27, 2018
A digital microfluidic system for serological immunoassays in remote settingsAlphonsus H C Ng, Ryan Fobel, Christian Fobel, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2025
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, et al.
JAMA Oncology|October 10, 2024
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging ClassificationJian-Ji Pan, Hai-Qiang Mai, Wai Tong Ng, et al.
The Lancet. Oncology|September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
The Lancet. Oncology|September 4, 2025
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
International Journal of Radiation Oncology, Biology, Physics|June 11, 2018
Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic RatioWai-Tong Ng, Stewart Y Tung, Victor Lee, et al.
The American Journal of Surgical Pathology|March 2, 2026
Does This Imaging Make Me Look NFATC2? The Value of Radiologic-pathologic Correlation in NFATC2-rearranged Sarcomas of BoneMichael E Kallen, Raul Perret, Gregory W Charville, et al.
Cancers|September 10, 2021
External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal CarcinomaPui-Lam Yip, Shing-Fung Lee, Cheuk-Wai Horace Choi, et al.
Targeted Oncology|January 12, 2022
A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in ChinaHai-Yan Tu, Jifeng Feng, Meiqi Shi, et al.
The Lancet. Oncology|June 21, 2013
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trialYi-Long Wu, Jin Soo Lee, Sumitra Thongprasert, et al.
Science Translational Medicine|April 27, 2018
A digital microfluidic system for serological immunoassays in remote settingsAlphonsus H C Ng, Ryan Fobel, Christian Fobel, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2025
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)Shao-Jun Lin, Qiao-Juan Guo, Qin Liu, et al.
JAMA Oncology|October 10, 2024
Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging ClassificationJian-Ji Pan, Hai-Qiang Mai, Wai Tong Ng, et al.
The Lancet. Oncology|September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
The Lancet. Oncology|September 4, 2025
Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlasLing-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Pageof 11